Targeted Therapy Promising For Cancer Patients

submitted by: mdanderson

Casey Carleton, a patient with metastatic melanoma explains his experience and success on Phase 1 clinical trial. Customizing targeted therapies to each tumor's molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center.